AVROBIO, INC. EXECUTIVE RETENTION PAYMENT AGREEMENTExecutive Retention Payment Agreement • August 10th, 2023 • AVROBIO, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Executive Retention Payment Agreement (“Agreement”) is made as of the 26th day of June, 2023, between AVROBIO, Inc., a Delaware corporation (the “Company”), and Steven Avruch (the “Executive”).
CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS OF THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. THIS REDACTED INFORMATION HAS BEEN MARKED IN THIS EXHIBIT WITH THREE ASTERISKS...Asset Purchase Agreement • August 10th, 2023 • AVROBIO, Inc. • Biological products, (no disgnostic substances) • Delaware
This ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of May 19, 2023, by and among Novartis Pharma AG, a company organized under the laws of Switzerland, Novartis Pharmaceuticals Corporation, a Delaware corporation (collectively, “Purchaser”) and AVROBIO, Inc., a Delaware corporation (the “Seller”). Each of Purchaser and the Seller, as the case may be, is referred to herein as a “Party”, and collectively as the “Parties”. Certain capitalized terms used in this Agreement are defined in Article 1.
